These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 34665783)

  • 1. Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccination.
    Cagigi A; Yu M; Österberg B; Svensson J; Falck-Jones S; Vangeti S; Åhlberg E; Azizmohammadi L; Warnqvist A; Falck-Jones R; Gubisch PC; Ödemis M; Ghafoor F; Eisele M; Lenart K; Bell M; Johansson N; Albert J; Sälde J; Pettie DD; Murphy MP; Carter L; King NP; Ols S; Normark J; Ahlm C; Forsell MN; Färnert A; Loré K; Smed-Sörensen A
    JCI Insight; 2021 Nov; 6(22):. PubMed ID: 34665783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral immunity to SARS-CoV-2 in kidney transplant recipients and dialysis patients: IgA and IgG patterns unraveled after SARS-CoV-2 infection and vaccination.
    De Bouver C; Bouziotis J; Wijtvliet VPWM; Ariën KK; Mariën J; Heyndrickx L; Couttenye MM; de Fijter HJW; Mestrez F; Treille S; Mat O; Collart F; Allard SD; Vingerhoets L; Moons P; Abramowicz D; De Winter BY; Pipeleers L; Wissing KM; Ledeganck KJ
    Virol J; 2024 Jun; 21(1):138. PubMed ID: 38872127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.
    Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y
    Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Healthcare Study Examines the Humoral Anti-S1 Antibody Response Following mRNA Vaccination, Comparing Individuals with and without Prior SARS-CoV-2 Infection.
    Staruszkiewicz M; Pituch-Noworolska A; Skayne M; Matthias T; Skoczen S
    Arch Immunol Ther Exp (Warsz); 2024 Jan; 72(1):. PubMed ID: 39146978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust Neutralizing Antibody Levels Detected after Either SARS-CoV-2 Vaccination or One Year after Infection.
    Glöckner S; Hornung F; Baier M; Weis S; Pletz MW; Deinhardt-Emmer S; Löffler B; The CoNAN Study Group
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates.
    Gagne M; Flynn BJ; Andrew SF; Marquez J; Flebbe DR; Mychalowych A; Lamb E; Davis-Gardner ME; Burnett MR; Serebryannyy LA; Lin BC; Ziff ZE; Maule E; Carroll R; Naisan M; Jethmalani Y; Pessaint L; Todd JM; Doria-Rose NA; Case JB; Dmitriev IP; Kashentseva EA; Ying B; Dodson A; Kouneski K; O'Dell S; Wali B; Ellis M; Godbole S; Laboune F; Henry AR; Teng IT; Wang D; Wang L; Zhou Q; Zouantchangadou S; Van Ry A; Lewis MG; Andersen H; Kwong PD; Curiel DT; Roederer M; Nason MC; Foulds KE; Suthar MS; Diamond MS; Douek DC; Seder RA
    Nat Immunol; 2024 Oct; 25(10):1913-1927. PubMed ID: 39227514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Kinetics of SARS-CoV-2 Antibodies and Impact of Inactivated Vaccine on SARS-CoV-2 Antibodies Based on a COVID-19 Patients Cohort.
    Zhang S; Xu K; Li C; Zhou L; Kong X; Peng J; Zhu F; Bao C; Jin H; Gao Q; Zhao X; Zhu L
    Front Immunol; 2022; 13():829665. PubMed ID: 35154152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term humoral and cellular immunity against vaccine strains and Omicron subvariants (BQ.1.1, BN.1, XBB.1, and EG.5) after bivalent COVID-19 vaccination.
    Hyun H; Nham E; Seong H; Yoon JG; Noh JY; Cheong HJ; Kim WJ; Yoon SK; Park SJ; Gwak W; Lee JW; Kim B; Song JY
    Front Immunol; 2024; 15():1385135. PubMed ID: 38756783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates.
    Corbett KS; Nason MC; Flach B; Gagne M; O'Connell S; Johnston TS; Shah SN; Edara VV; Floyd K; Lai L; McDanal C; Francica JR; Flynn B; Wu K; Choi A; Koch M; Abiona OM; Werner AP; Moliva JI; Andrew SF; Donaldson MM; Fintzi J; Flebbe DR; Lamb E; Noe AT; Nurmukhambetova ST; Provost SJ; Cook A; Dodson A; Faudree A; Greenhouse J; Kar S; Pessaint L; Porto M; Steingrebe K; Valentin D; Zouantcha S; Bock KW; Minai M; Nagata BM; van de Wetering R; Boyoglu-Barnum S; Leung K; Shi W; Yang ES; Zhang Y; Todd JM; Wang L; Alvarado GS; Andersen H; Foulds KE; Edwards DK; Mascola JR; Moore IN; Lewis MG; Carfi A; Montefiori D; Suthar MS; McDermott A; Roederer M; Sullivan NJ; Douek DC; Graham BS; Seder RA
    Science; 2021 Sep; 373(6561):eabj0299. PubMed ID: 34529476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal vaccination of triple-RBD scaffold protein with flagellin elicits long-term protection against SARS-CoV-2 variants including JN.1.
    Li X; Xu M; Yang J; Zhou L; Liu L; Li M; Wang S; Liu MQ; Huang Z; Zhang Z; Liu S; Hu Y; Lin H; Liu B; Sun Y; Wu Q; Shi ZL; Lan K; Chen Y; Yan H; Chen YQ
    Signal Transduct Target Ther; 2024 Apr; 9(1):114. PubMed ID: 38678055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals.
    Butler SE; Crowley AR; Natarajan H; Xu S; Weiner JA; Bobak CA; Mattox DE; Lee J; Wieland-Alter W; Connor RI; Wright PF; Ackerman ME
    Front Immunol; 2020; 11():618685. PubMed ID: 33584712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection.
    Gallais F; Gantner P; Bruel T; Velay A; Planas D; Wendling MJ; Bayer S; Solis M; Laugel E; Reix N; Schneider A; Glady L; Panaget B; Collongues N; Partisani M; Lessinger JM; Fontanet A; Rey D; Hansmann Y; Kling-Pillitteri L; Schwartz O; De Sèze J; Meyer N; Gonzalez M; Schmidt-Mutter C; Fafi-Kremer S
    EBioMedicine; 2021 Sep; 71():103561. PubMed ID: 34455390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating Humoral Immunity Elicited by XBB.1.5 Monovalent COVID-19 Vaccine.
    Nguyenla XH; Bates TA; Trank-Greene M; Wahedi M; Tafesse FG; Curlin ME
    Emerg Infect Dis; 2024 Jun; 30(6):1282-1283. PubMed ID: 38669121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques.
    McMahan K; Wegmann F; Aid M; Sciacca M; Liu J; Hachmann NP; Miller J; Jacob-Dolan C; Powers O; Hope D; Wu C; Pereira J; Murdza T; Mazurek CR; Hoyt A; Boon ACM; Davis-Gardner M; Suthar MS; Martinot AJ; Boursiquot M; Cook A; Pessaint L; Lewis MG; Andersen H; Tolboom J; Serroyen J; Solforosi L; Costes LMM; Zahn RC; Barouch DH
    Nature; 2024 Feb; 626(7998):385-391. PubMed ID: 38096903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Durable antibody response one year after hospitalization for COVID-19: A longitudinal cohort study.
    Masiá M; Fernández-González M; Telenti G; Agulló V; García JA; Padilla S; García-Abellán J; Galiana A; Gonzalo-Jiménez N; Gutiérrez F
    J Autoimmun; 2021 Sep; 123():102703. PubMed ID: 34303083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study.
    He Z; Ren L; Yang J; Guo L; Feng L; Ma C; Wang X; Leng Z; Tong X; Zhou W; Wang G; Zhang T; Guo Y; Wu C; Wang Q; Liu M; Wang C; Jia M; Hu X; Wang Y; Zhang X; Hu R; Zhong J; Yang J; Dai J; Chen L; Zhou X; Wang J; Yang W; Wang C
    Lancet; 2021 Mar; 397(10279):1075-1084. PubMed ID: 33743869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19.
    Mazzoni A; Di Lauria N; Maggi L; Salvati L; Vanni A; Capone M; Lamacchia G; Mantengoli E; Spinicci M; Zammarchi L; Kiros ST; Rocca A; Lagi F; Colao MG; Parronchi P; Scaletti C; Turco L; Liotta F; Rossolini GM; Cosmi L; Bartoloni A; Annunziato F;
    J Clin Invest; 2021 Jun; 131(12):. PubMed ID: 33939647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preservation of Anti-SARS-CoV-2 Neutralizing Antibodies in Breast Milk: Impact of Maternal COVID-19 Vaccination and Infection.
    Suteerojntrakool O; Mekangkul E; Maitreechit D; Khabuan S; Sodsai P; Hirankarn N; Thumbovorn R; Chomtho S
    Breastfeed Med; 2024 May; 19(5):340-348. PubMed ID: 38506333
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-SARS-CoV-2 Immunoglobulin Isotypes, and Neutralization Activity Against Viral Variants, According to BNT162b2-Vaccination and Infection History.
    Tarkowski M; de Jager W; Schiuma M; Covizzi A; Lai A; Gabrieli A; Corbellino M; Bergna A; Ventura CD; Galli M; Riva A; Antinori S
    Front Immunol; 2021; 12():793191. PubMed ID: 34975897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.